Optibiotix Health Share Discussion Threads

[elrico] 27/10/2016 11:17

And let us not forget the wisdom of michaelmouse. He advocates investors should buy more Avanti on the back of false rumours Avanti would be bought out when the share price was 48p. Anyone foolish enough to listen to his wisdom and his ranmplings on his blog would now have compounded their historical heavy losses even more by losing half again!

By now we know michaelmouse is immune to factual critical comments. I'm sure psychologist's have a description for this. I won't get into that.

[elrico] 27/10/2016 11:04

Interesting spin, especially the topic of the share price. Remind us of your two darling "growth" investments on a 12 month view.

Avanti; THE FRAUD! 250p now 24.5p
Trakm8: The cash guzzler and creative accounting magician 360p now 156p. But to be fair, you got a maiden 2p divi. Shame it can't afford it. Isn't that the same trick a number of Chinese frauds use to sucker investors in!

You should be ashamed AIMHO!

[someuwin] 27/10/2016 10:56

The good news is that there isn't going to be just one cholesterol product but a whole pipeline of cardiovascular products. Aimed at different markets and different consumers and different regions.

Food additives / ingredients. Supplements. And Pharma. They are working with multiple partners to bring many products to market. a pure phama statin alternative is a strong possibility - but will take longer for a partner to get to market. Meanwhile the other products will be generating cash much quicker.

[smarner] 27/10/2016 10:39

Be nice if the cholestorol priduct was prescribed bg GPs instead of statins.Same with product for diabetes. At the moment anyone diagnosed as type 2 is prescribed Metformin which originally was a weight loss drug. It made me feel 20 yrs older and gave me a stiff back. Stopped taking it after suffering for 3 yrs and feel like a new person. Huge market and growing!

[elrico] 27/10/2016 09:53

View it as a mark of respect from a bear.

[dogwalker] 27/10/2016 09:24

Thanks again, somewin. (Why would anyone mark your helpful post with a thumbs down ?!)

[judijudi] 27/10/2016 09:18

Could be an interesting day one way or tother

[someuwin] 27/10/2016 09:14

OPTI will be presenting the results of their research developments at the microbiome summit next week. So I'd imagine we'll get an RNS to coincide. Maybe next Thursday?

[michaelmouse] 27/10/2016 09:08

Oh yes, all IMHO of course.

[rafboy] 27/10/2016 09:05

Agree it is a bit disappointing not to see the share price rise very much on what was a positive RNS yesterday. I am sure it will happen though and not that long to wait. Going to be an interesting 6 months or so I suspect.

[dogwalker] 27/10/2016 09:04

That's right , Woodaldo. Converting hard science into hard cash has never proved easy.This company has nothing if not potential.Re the cash aspect, an 'exciting 2016' has been morphed into an 'exciting 2017', as explained in detail yesterday.
My only concern is that SOH holds back from striking deals just a little too long, allowing others to step in, with second-rate products,& taking our slice of the cake.

[parob] 27/10/2016 09:02

Totally agree. And on my walk to work this morning I've been thinking about combination products, I.e. combining the product with plant sterols (the likes of benecol) then you're looking at C30% reduction. Imagine the negotiating position SOH is in with partners/food manufacturers etc. The market will catch on at some point.

[woodaldo] 27/10/2016 08:55

Exactly parob, if a pharma introduced these results for a new safer statin product the share price would go off the wall, even if it was a couple of years from going to market. It's a weird malaise that has gripped this company's share price lately, and yet all the signs going forward look excellent. I appreciate its been a long year for us LTH's regarding the SP, but I honestly think this company will be worth much much more within 3-6 months once the market catches on and one of the big RNS's lands.

[bdog51] 27/10/2016 08:33

Some strong buying so far today..

[michaelmouse] 27/10/2016 08:11

Just out of interest, on the main thread you were all reporting that SOH said 4/5 blockbuster agreements with multi-nationals were soon to be announced. In fact you've been repeating this mantra all year.

Yesterday's (supposed) e-mail from SOH is a complete about turn:-

"Groups experienced in this area will appreciate that whilst its easier to give rights to one group you then lose control and have a dependence on that company. AIM is littered with companies who have struck early commercial deals with big partners who then lost interest and then have nowhere to go. Whilst painful and timeconsuming as the RNS states multiple deals diversifies investor risk and if successful will give a greater shareholder return."

When exactly was his Damascus moment then?

IC rec. may provide a small lift this am. It won't last though. Any rises now will be sold into.

[parob] 27/10/2016 08:03

From the cholesterol results RNS in April:- 7.2% reduction in LDL cholesterol (bad cholesterol) averaged across the whole test groupSo we're looking at over 21% reduction on average across the general population and no doubt much higher in the higher risk groups.This really is very significant IMO.

[parob] 27/10/2016 07:53

At the end of this proactive news article from yesterday:http://www.proactiveinvestors.co.uk/companies/news/167976/optibiotix-health-targeting-spring-for-cardiovascular-products-launch-167976.html Broker FinnCap said: "By combining Optiscreens LDL cholesterol reducing strain with its own novel OptiBiotix sugars, management have demonstrated a threefold increase in the products' capability to lower Low Density Cholesterol (LDL) in human gut models."Analyst Alex Pye added: "With its Slimbiome, GoFigure product range already on the market and steadily gaining consumer attention, we are encouraged by the progress being made in commercialisation of its novel microbiome modulating technologies."

[michaelmouse] 27/10/2016 07:24

The problem that OptiBiotix are having is that their attempts to pump up their share price before attempting a fund raise are falling on deaf ears. In fact each news release causes a dip in the share price.

It now appears that any imminent news of a blockbuster deal is dead in the water.

I think my prediction of a fund raise at 40p is possibly too generous.

[michaelmouse] 27/10/2016 07:20

"Luckily for them, and just a few days before their half-year results are released, MED2002 put some lead into their pencil which in turn should help with another raising. A dilutive fundraising will inevitably be announced in the next few weeks (if not next week)."



"The Company announced on 27 October 2016 that it is seeking to raise up to £12 million (before expenses) through the placing with existing and new institutional investors of up to 21,052,632 New Ordinary Shares at a price of 57 pence per Ordinary Share.
 
The Placing Price represents a 13.0 per cent. discount to the Closing Price of 65.5 pence per Ordinary Share on 26 October 2016 (being the last Business Day prior to the announcement of the Placing)."

"The Placing Shares will represent up to approximately 17.5 per cent. of the Enlarged Share Capital."

I'm rather good at anticipating fund raisings don't you think?
 

[siennadelekat21] 27/10/2016 04:57

Yep Mouse20,Even suggestions that their diet versions could be bad too : )hTTp://www.telegraph.co.uk/news/2016/10/21/two-diet-drinks-a-day-could-double-the-risk-of-diabetes-study-fi/Sienna

[mazzstar] 26/10/2016 20:56

I don't need Xmas funds but hope the share price will be above 80p when news arrives. As for the website, I am interested to see if SOH keeps his word about updating it by the end of the month as mentioned in his email to someuwin.

[mouse20] 26/10/2016 20:49

Coke sales continue to lose their fizz



Levels of high sugar now impacting on sales as awareness of negative impact of excess sugar grows.
Need a new healthy sugar to boost their flagging sales!!!

[elrico] 26/10/2016 20:43

Good observation - someuwin. I would like to be an Hilder Ogden around their table.

Mazz - ignore the share price unless you need Christmas funds. Ref website. Why would the company waste funds on window dressing when each division will need it's own website. It's an unwelcome distraction that can be tackled at a more opportune time.